Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
|
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
|---|---|---|---|---|---|---|---|---|---|
| PAAD | rs112100165 | chr10:102944381 | G/C | 8.58E-8 | 175 | 15.82 | 13.6 | 3.17 | KM Plot |
| PAAD | rs112113025 | chr1:216266432 | G/A | 0 | 175 | 14.63 | 17.33 | 0.4 | KM Plot |
| PAAD | rs112123925 | chr1:227565170 | A/AT | 6.96E-5 | 176 | 15.4 | 16.45 | 3.9 | KM Plot |
| PAAD | rs112152644 | chr1:162831227 | ATT/A | 1.01E-5 | 176 | 15.33 | 16.27 | 6.5 | KM Plot |
| PAAD | rs11220173 | chr11:125520600 | G/T | 4.72E-5 | 178 | 16.03 | 11.6 | 4.1 | KM Plot |
| PAAD | rs11220174 | chr11:125520645 | T/C | 4.72E-5 | 178 | 16.03 | 11.6 | 4.1 | KM Plot |
| PAAD | rs11220182 | chr11:125543728 | A/G | 5.12E-5 | 176 | 16.03 | 11.6 | 4.1 | KM Plot |
| PAAD | rs11220183 | chr11:125551090 | A/G | 4.72E-5 | 178 | 16.03 | 11.6 | 4.1 | KM Plot |
| PAAD | rs11220185 | chr11:125565219 | G/A | 7.15E-5 | 177 | 16.08 | 14.18 | 5.03 | KM Plot |
| PAAD | rs11220186 | chr11:125565843 | G/A | 4.48E-5 | 177 | 16.05 | 11.6 | 4.1 | KM Plot |
| PAAD | rs11220188 | chr11:125573850 | G/A | 0.000101 | 176 | 16.03 | 11.6 | 4.1 | KM Plot |
| PAAD | rs11220193 | chr11:125588415 | A/G | 4.72E-5 | 178 | 16.03 | 11.6 | 4.1 | KM Plot |
| PAAD | rs11220197 | chr11:125592246 | G/A | 9.4E-5 | 178 | 16.1 | 14.18 | 5.03 | KM Plot |
| PAAD | rs11220198 | chr11:125592428 | A/G | 9.4E-5 | 178 | 16.1 | 14.18 | 5.03 | KM Plot |
| PAAD | rs11220200 | chr11:125596929 | A/G | 0.00011 | 177 | 16.08 | 14.18 | 5.03 | KM Plot |